http://www.prnewswire.com/rss/health/pharmaceuticals-news.rss Press Releases from PR Newswire about Pharmaceuticals en-us Wed, 22 May 2013 11:00:22 EDT Wed, 22 May 2013 10:54:00 EDT http://www.prnewswire.com/news-releases/kepner-tregoe-inc-befordert-chris-geraghty-zum-hauptgeschaftsfuhrer-208488311.html http://www.prnewswire.com/news-releases/kepner-tregoe-inc-befordert-chris-geraghty-zum-hauptgeschaftsfuhrer-208488311.html Wed, 22 May 2013 10:54:00 EDT - Der ehemalige Geschäftsführer ersetzt Ray Baxter; wird sich auf Vision und Wachstum konzentrieren PRINCETON, New Jersey, 22. Mai 2013 /PRNewswire/ -- Kepner-Tregoe (KT), das globale Unternehmen für Fähigkeitsentwicklung und Beratung, gab heute bekannt, dass der...

]]>

]]> PRNewswire de PR Newswire Association LLC. http://www.prnewswire.com/news-releases/kepner-tregoe-inc-nomme-chris-geraghty-aux-fonctions-de-directeur-general-208487271.html http://www.prnewswire.com/news-releases/kepner-tregoe-inc-nomme-chris-geraghty-aux-fonctions-de-directeur-general-208487271.html Wed, 22 May 2013 10:46:00 EDT - L'ancien directeur d'exploitation remplace Ray Baxter et se concentrera sur la vision et la croissance de l'entreprise PRINCETON, New Jersey, 22 mai 2013 /PRNewswire/ -- Kepner-Tregoe (KT), la société mondiale de développement des capacités et de conseil en...

]]>

]]> PRNewswire fr PR Newswire Association LLC. http://www.prnewswire.com/news-releases/scientific-and-technical-evaluation-of-pharmaceuticals-inc-steph-inc-launches-new-competitive-intelligence-web-site-208483861.html http://www.prnewswire.com/news-releases/scientific-and-technical-evaluation-of-pharmaceuticals-inc-steph-inc-launches-new-competitive-intelligence-web-site-208483861.html Wed, 22 May 2013 10:26:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/jot-automation-has-delivered-manufacturing-solution-for-tandem-diabetes-care-208478931.html http://www.prnewswire.com/news-releases/jot-automation-has-delivered-manufacturing-solution-for-tandem-diabetes-care-208478931.html Wed, 22 May 2013 09:54:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/type-2-diabetes-control-worsening-according-to-study-of-patients-on-commercial-insurance-208477681.html http://www.prnewswire.com/news-releases/type-2-diabetes-control-worsening-according-to-study-of-patients-on-commercial-insurance-208477681.html Wed, 22 May 2013 09:43:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/upsher-smith-successfully-completes-phase-iii-study-of-usl255-extended-release-topiramate-for-adjunctive-treatment-of-epilepsy-in-patients-with-refractory-partial-onset-seizures-208475701.html http://www.prnewswire.com/news-releases/upsher-smith-successfully-completes-phase-iii-study-of-usl255-extended-release-topiramate-for-adjunctive-treatment-of-epilepsy-in-patients-with-refractory-partial-onset-seizures-208475701.html Wed, 22 May 2013 09:30:00 EDT MAPLE GROVE, Minn., May 22, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/ranbaxy-announces-improved-business-standards-and-quality-assurance-initiatives-208472601.html http://www.prnewswire.com/news-releases/ranbaxy-announces-improved-business-standards-and-quality-assurance-initiatives-208472601.html Wed, 22 May 2013 09:09:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/avanir-pharmaceuticals-to-participate-in-two-upcoming-investor-conferences-208470841.html http://www.prnewswire.com/news-releases/avanir-pharmaceuticals-to-participate-in-two-upcoming-investor-conferences-208470841.html Wed, 22 May 2013 09:00:00 EDT ALISO VIEJO, Calif., May 22, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following conferences. Deutsche Bank 38th Annual Health Care Conference Presentation date:...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/par-pharmaceutical-begins-shipment-of-generic-atacand-208470931.html http://www.prnewswire.com/news-releases/par-pharmaceutical-begins-shipment-of-generic-atacand-208470931.html Wed, 22 May 2013 09:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/generex-announces-asco-presentations-on-the-antigen-express-advanced-stage-ae37-cancer-vaccine-208470981.html http://www.prnewswire.com/news-releases/generex-announces-asco-presentations-on-the-antigen-express-advanced-stage-ae37-cancer-vaccine-208470981.html Wed, 22 May 2013 09:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/grifols-study-demonstrates-higher-dose-of-prolastin-c-increases-levels-of-alpha1-pi--to-within-normal-range-in-patients-with-aat-deficiency-208468911.html http://www.prnewswire.com/news-releases/grifols-study-demonstrates-higher-dose-of-prolastin-c-increases-levels-of-alpha1-pi--to-within-normal-range-in-patients-with-aat-deficiency-208468911.html Wed, 22 May 2013 08:47:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/studie-von-grifols-zeigt-dass-eine-hohere-dosis-von-prolastin-c-den-alpha1-pi-spiegel-in-patienten-mit-aat-mangel-in-den-normalen-bereich-anhebt-208468881.html http://www.prnewswire.com/news-releases/studie-von-grifols-zeigt-dass-eine-hohere-dosis-von-prolastin-c-den-alpha1-pi-spiegel-in-patienten-mit-aat-mangel-in-den-normalen-bereich-anhebt-208468881.html Wed, 22 May 2013 08:47:00 EDT de PR Newswire Association LLC. http://www.prnewswire.com/news-releases/lo-studio-grifols-dimostra-che-dosi-piu-elevate-di-prolastin-c-aumentano-i-livelli-di-alfa1-pi-portandoli-ai-valori-normali-nei-pazienti-affetti-da-deficit-di-alfa1-antitripsina-208468901.html http://www.prnewswire.com/news-releases/lo-studio-grifols-dimostra-che-dosi-piu-elevate-di-prolastin-c-aumentano-i-livelli-di-alfa1-pi-portandoli-ai-valori-normali-nei-pazienti-affetti-da-deficit-di-alfa1-antitripsina-208468901.html Wed, 22 May 2013 08:47:00 EDT it PR Newswire Association LLC. http://www.prnewswire.com/news-releases/life-science-industry-veteran-stephane-bancel-joins-flagship-ventures-208468151.html http://www.prnewswire.com/news-releases/life-science-industry-veteran-stephane-bancel-joins-flagship-ventures-208468151.html Wed, 22 May 2013 08:38:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/abbott-to-present-at-deutsche-bank-38th-annual-health-care-conference-208466671.html http://www.prnewswire.com/news-releases/abbott-to-present-at-deutsche-bank-38th-annual-health-care-conference-208466671.html Wed, 22 May 2013 08:30:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/puracaps-team-epiceram-joins-walk-to-cure-eczema-208466661.html http://www.prnewswire.com/news-releases/puracaps-team-epiceram-joins-walk-to-cure-eczema-208466661.html Wed, 22 May 2013 08:30:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/ohr-pharmaceutical-appoints-june-s-almenoff-to-board-of-directors-208466831.html http://www.prnewswire.com/news-releases/ohr-pharmaceutical-appoints-june-s-almenoff-to-board-of-directors-208466831.html Wed, 22 May 2013 08:30:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/rosetta-genomics-to-present-at-the-jefferies-2013-healthcare-conference-208467221.html http://www.prnewswire.com/news-releases/rosetta-genomics-to-present-at-the-jefferies-2013-healthcare-conference-208467221.html Wed, 22 May 2013 08:30:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/myths-debunked-underage-drinking-of-alcohol-at-home-leads-to-real-consequences-for-both-parents-and-teens-208464611.html http://www.prnewswire.com/news-releases/myths-debunked-underage-drinking-of-alcohol-at-home-leads-to-real-consequences-for-both-parents-and-teens-208464611.html Wed, 22 May 2013 08:06:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/cellular-biomedicine-group-announces-enrollment-milestone-for-phase-i-clinical-trial-for-liver-cancer-208463611.html http://www.prnewswire.com/news-releases/cellular-biomedicine-group-announces-enrollment-milestone-for-phase-i-clinical-trial-for-liver-cancer-208463611.html Wed, 22 May 2013 08:01:00 EDT en-US PR Newswire Association LLC.